Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 119,560 shares of the company's stock, valued at approximately $4,091,000.
A number of other institutional investors have also recently made changes to their positions in the business. Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of Keurig Dr Pepper by 53.1% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 325,398 shares of the company's stock valued at $10,400,000 after buying an additional 112,819 shares during the period. RWC Asset Management LLP lifted its holdings in Keurig Dr Pepper by 34.6% in the fourth quarter. RWC Asset Management LLP now owns 1,553,095 shares of the company's stock valued at $49,885,000 after acquiring an additional 398,916 shares during the period. Oppenheimer & Co. Inc. acquired a new position in Keurig Dr Pepper in the fourth quarter valued at approximately $400,000. Concurrent Investment Advisors LLC boosted its position in Keurig Dr Pepper by 185.8% in the 4th quarter. Concurrent Investment Advisors LLC now owns 51,611 shares of the company's stock worth $1,658,000 after purchasing an additional 33,554 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Keurig Dr Pepper during the 4th quarter worth approximately $57,995,000. Institutional investors and hedge funds own 93.99% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have weighed in on KDP. HSBC upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and upped their price objective for the stock from $36.00 to $42.00 in a research report on Friday, April 25th. Piper Sandler raised Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $35.00 to $40.00 in a report on Wednesday, April 9th. Wells Fargo & Company reissued an "overweight" rating on shares of Keurig Dr Pepper in a report on Tuesday, February 25th. Hsbc Global Res raised Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research note on Friday, April 25th. Finally, Barclays increased their target price on Keurig Dr Pepper from $37.00 to $38.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Four investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $39.33.
Read Our Latest Stock Analysis on KDP
Insider Buying and Selling at Keurig Dr Pepper
In related news, VP Angela A. Stephens sold 14,500 shares of the stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total transaction of $496,480.00. Following the transaction, the vice president now owns 62,411 shares of the company's stock, valued at approximately $2,136,952.64. This represents a 18.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the firm's stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $35.59, for a total value of $427,080.00. Following the transaction, the insider now owns 154,511 shares of the company's stock, valued at $5,499,046.49. This trade represents a 7.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 698,500 shares of company stock valued at $23,591,400 over the last 90 days. 0.40% of the stock is owned by insiders.
Keurig Dr Pepper Trading Up 0.2%
Shares of Keurig Dr Pepper stock traded up $0.08 during mid-day trading on Monday, hitting $33.10. The stock had a trading volume of 8,379,343 shares, compared to its average volume of 10,821,698. The firm has a 50-day moving average of $33.90 and a two-hundred day moving average of $33.08. The firm has a market cap of $44.96 billion, a P/E ratio of 20.06, a price-to-earnings-growth ratio of 2.42 and a beta of 0.48. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper Inc. has a 12-month low of $30.12 and a 12-month high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The company had revenue of $3.64 billion during the quarter, compared to analysts' expectations of $3.57 billion. During the same quarter last year, the firm earned $0.38 earnings per share. The firm's quarterly revenue was up 4.8% compared to the same quarter last year. Sell-side analysts forecast that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.23 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.92 annualized dividend and a yield of 2.78%. Keurig Dr Pepper's dividend payout ratio (DPR) is currently 83.64%.
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report